BrainStorm Cell Therapeutics Inc (BCLI)

[bubbarayjr]

AMLX paves the way for BCLI: 10+ Bagger - Wall Street is asleep on this one.
FDA's Panel nod to AMLX for ALS means FDA acceptance of BCLI's BLA a certainty imo.

The transcript of BCLI's BLA announcement: https://seekingalpha.com/article/4534421-brainstorm-cell-therapeutics-inc-s-bcli-ceo-chaim-lebovits-on-q2-2022-results-earnings-call

Correcting the statistical model for a key Pre-specified Secondary Endpoint resulted in a statistically significant improvement for patients in this sub-group.

This is huge but here's the kicker. The FDA has been putting more emphasis on how ALS treatments affect key Biomarkers. NurOwn improved 3 very important markers in patients who responded favorably. **AND** BCLI will publish this Biomarker data in a PEER REVIEWED JOURNAL in the very near future.

With a Market Cap of $138M, BCLI compared to AMLX Market Cap nearing $2B, it's a 10+ Bagger.